Roche Wins First U.S. Approval for New Breast-Cancer Pill
The FDA approved Roche’s pill to treat advanced breast cancer, the first approval for the medicine.
By Adria CalatayudRoche Holding received the green light from the U.S. Food and Drug Administration to launch a new pill to treat advanced breast cancer, the first approval for what executives say could become the company's top-selling product.The Swiss drugmaker said late Monday that the medicine…